Our research is used by our industry clients to inform payer/Health Technology Assessment (HTA) authority decisions about the availability, access, pricing, and reimbursement of new healthcare technologies. Activities may include supporting literature reviews, evidence synthesis, and providing support for other colleagues in the Health Economics practice area.